- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
M2Gen
M2Gen is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small business
Real World Evidence & Data
- Secondary Real World Evidence Analyze clinical trial data.
Where it operates
Sites by country, with the cities in each.
-
United States 1 site
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
M2Gen®, H. Lee Moffitt Cancer Center & Research Institute’s wholly owned, for-profit subsidiary, advances personalized medicine by using high quality tissue, clinical data and molecular technology to advance personalized cancer treatments. M2Gen partners with pharmaceutical and biotech companies to: Use data to enhance trial design & enrollment for pharma Reduce "guess work" associated with drug development Enable development of companion diagnostics Position drugs for accelerated approvals Speed enrollment of trials To achieve this, M2Gen, along with Moffitt Cancer Center and the 17...
Show the full description
M2Gen®, H. Lee Moffitt Cancer Center & Research Institute’s wholly owned, for-profit subsidiary, advances personalized medicine by using high quality tissue, clinical data and molecular technology to advance personalized cancer treatments.
M2Gen partners with pharmaceutical and biotech companies to:
- Use data to enhance trial design & enrollment for pharma
- Reduce "guess work" associated with drug development
- Enable development of companion diagnostics
- Position drugs for accelerated approvals
- Speed enrollment of trials
To achieve this, M2Gen, along with Moffitt Cancer Center and the 17 hospitals in our Consortium Network, have created the world’s largest cancer-focused biorepository linked to longitudinal clinical and derived molecular data. With more than 85,000 patients across the United States currently enrolled in our long-term observational research study, M2Gen has collected more than 40,000 tumor specimens. Over 300 new patients enroll in the study each week – vastly expanding M2Gen’s knowledge base of clinical, pathologic, demographic, and biomarker data.
- Website
- www.m2gen.com
Work with M2Gen on Scientist.com
For prices, more details, or to contact M2Gen, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.